HOCHSCHULE REUTLINGEN

Immune cell therapy

Research activities Mittelstät-Lab 

 

The research focus is on technologies and processes for the production and administration of cell and gene therapeutics, in particular using novel biomaterials, as well as the optimisation of cellular immunotherapeutics such as chimeric antigen receptor modified T cells (CAR T cells) for the treatment of cancer.

Current research projects

The project involves conducting a pilot study to develop a simplified manufacturing process for generating optimised CAR T cells.

Duration: until 10/2026

Contact:Prof. Dr Jörg Mittelstät

Contact person